By Ryan Davis ( October 30, 2012, 5:55 PM EDT) -- Biogen Idec MA Inc. has become the latest company to challenge the U.S. Patent and Trademark Office's calculation of patent term adjustments, arguing in a suit filed in Virginia that the term of its patent on a compound used to treat neuronal dysfunction should be extended by 125 days....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.